More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.30B
EPS
9.78
P/E ratio
31.2
Price to sales
3.54
Dividend yield
--
Beta
1.086254
Previous close
$298.54
Today's open
$302.52
Day's range
$293.99 - $304.74
52 week range
$173.86 - $342.11
show more
CEO
R. Jeffrey Bailly
Employees
4846
Headquarters
Newburyport, MA
Exchange
NASDAQ Capital Market
Shares outstanding
7746986
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
UFP Technologies: 3 Key Takeaways for Long-Term Investors
UFP Technologies reported third-quarter sales of $172.4 million, up 11.6%. Third-quarter gross margin reached 29.4%, up from 27.7% last year.
The Motley Fool • Nov 5, 2026

What UFP Technologies (UFPT) Said on Its Q3 Earnings Call
UFP Technologies NASDAQ: UFPT reported third-quarter 2026 sales growth of 11.6%, supported by broad demand across its medical technology portfolio, while management outlined continued investments in capacity, operational improvements and acquisitions heading into 2027.
MarketBeat • Nov 4, 2026

UFP Technologies, Inc. (UFPT) Q3 2026 Earnings Call Transcript
UFP Technologies, Inc. ( UFPT ) Q3 2026 Earnings Call November 4, 2026 8:30 AM EST Company Participants Ronald Lataille - CFO, Senior VP & Treasurer Mitchell Rock - President, CEO & Director Conference Call Participants Justin Ages - CJS Securities, Inc. Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Andrew Cooper - Raymond James & Associates, Inc., Research Division Luke Fingerson Presentation Operator Good day, and welcome to UFP Technologies' Third Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note that this event is being recorded.
Seeking Alpha • Nov 4, 2026

UFP Technologies Announces Strong Q3 Results
NEWBURYPORT, Mass.--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today reported net income of $20.6 million for its third quarter ended September 30, 2026, 25.8% higher than net income of $16.4 million for the third quarter of 2025. Net sales for the quarter ended September 30, 2026 were $172.4 millio.
Business Wire • Nov 3, 2026

UFP Technologies (UFPT) Q3 Earnings and Revenues Surpass Estimates
UFP Technologies (UFPT) came out with quarterly earnings of $2.88 per share, beating the Zacks Consensus Estimate of $2.63 per share. This compares to earnings of $2.39 per share a year ago.
Zacks Investment Research • Nov 4, 2026

UFP Technologies to Report Third Quarter 2026 Financial Results on November 3, 2026
NEWBURYPORT, Mass.--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the third quarter on Tuesday, November 3rd, after the close of the stock market. The Company will hold a conference call to discuss the results on the following day, November 4.
Business Wire • Oct 29, 2026

Diamond Hill Small Cap Fund Q3 2026 Portfolio Activity
Utz Brands shares rose after entering into an agreement to be acquired by Intersnack, a privately held European leader in savory snacks. Shares of health care management company Astrana Health declined during the quarter as selling pressure emerged following a strong first half of 2026. We initiated a position in Bank7, given its highly profitable, branch-light model and recent acquisition of Century Bank, which we believe should meaningfully enhance earnings.
Seeking Alpha • Oct 28, 2026

Implied Volatility Surging for UFP Technologies Stock Options
Investors need to pay close attention to UFPT stock based on the movements in the options market lately.
Zacks Investment Research • Sep 9, 2026

3 Medical Instruments Stocks Banking on GenAI to Tackle Industry Woes
GenAI offers growth potential for VCYT, GMED and UFPT, but regulatory and technology risks are likely to challenge adoption across healthcare.
Zacks Investment Research • Sep 9, 2026

UFP Technologies Director Cynthia Feldmann Sells 1,000 Shares
The sale represents a total value of $324,260. The disposition was executed entirely through direct ownership, leaving the insider with 4,476 shares held directly.
The Motley Fool • Aug 31, 2026

¹ Disclosures

Open an M1 investment account to buy and sell UFP Technologies Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.